FDA spokesperson discusses ongoing anti-counterfeiting efforts In an exclusive interview with Healthcare Packaging, FDA spokesperson Sarah Clark-Lynn addresses the role of supply chain shareholders and packaging in anti-counterfeiting efforts. By Jim Butschli, Editor-in-chief

In October, the U.S. Food and Drug Administration, in partnership with international regulatory regulatory and law enforcement agencies, took action against more than 4,100 Internet pharmacies that illegally sold potentially dangerous, unapproved drugs to consumers.

Here’s what FDA spokesperson Sarah Clark-Lynn had to say about counterfeiting and the role of packaging in anti-counterfeiting efforts:
HCP: How significant is this action with regard to pharmaceutical counterfeiting? Is this the first time such a broad-based global effort has resulted in such action? Could this beginning of further global actions?

Continue reading here